COMMUNIQUÉS West-GlobeNewswire

GlenBrook Health Center Named Great Place to Work

30/07/2018 - 20:51

CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- GlenBrook Health Center in Carlsbad, California, has been certified as a top workplace by the independent research and consulting firm Great Place to Work ®. Great [...]

Dynavax to Host Second Quarter 2018 Financial Results Conference Call

30/07/2018 - 20:45

Update on HEPLISAV-B® and Timing of Oncology Data BERKELEY, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will report financial results for the second [...]

FDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple Myeloma

30/07/2018 - 20:24

CAMBRIDGE, Mass., July 30, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]

BrightGuard Installs Free Sunscreen Dispensers Throughout Los Angeles Beach Cities

30/07/2018 - 19:02

First-of-its-Kind Automated Sunscreen Dispenser Company Collaborates with UCLA Health and IMPACT Melanoma to Provide Free, High-Quality Sunscreen to Help Reduce LA’s Risk of Skin Cancer LOS ANGELES and NEWPORT BEACH, [...]

Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific Officer

30/07/2018 - 19:00

SEATTLE, July 30, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies for patients with hematologic malignancies and other critical diseases, today announced the [...]

GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions

30/07/2018 - 18:19

Villepinte (France), le 30 juillet 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur [...]

Ossur Hf : Transactions in relation to share buyback program

30/07/2018 - 18:01

Announcement no. 48/2018 30 July 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]

Segra Closes $7.2 Million CAD Private Placement to Develop Industrial-Scale Cannabis Micropropagation Facilities

30/07/2018 - 18:00

VANCOUVER, British Columbia, July 30, 2018 (GLOBE NEWSWIRE) -- Segra International Corp. (“ Segra ” or the “ Company ”) is pleased to announce the successful closing of an oversubscribed private placement offering of [...]

Nextech Takes Home Practice Management Award at the 8th Annual Aesthetic Awards

30/07/2018 - 16:55

Plastic surgery-specific software acknowledged as industry-leading practice management tool TAMPA, Fla., July 30, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of healthcare technology solutions for [...]

UPDATE: Tauriga Sciences, Inc. Shares Now Listed on OTCQB Marketplace; Up-List Effective at Open of Trading Monday July 30, 2018

30/07/2018 - 15:59

NEW YORK, NY, July 30, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB: TAUG) (OTCQB: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]

Scythian Biosciences to Acquire Company with Exclusive Medical Cannabis License in Florida

30/07/2018 - 15:15

Company to Acquire Established Cultivator in State Where Medical Cannabis Sales Estimated to Hit $2.5 Billion 1 Also to own Florida-Based Multi-Specialty Medical Organization which Currently Employs Over 30 Full-Time or [...]

Dazzling Las Vegas Cannabis Dispensary and Entertainment Superstore Coming in November -- CFN Media

30/07/2018 - 15:00

SEATTLE, July 30, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

Naturally Splendid Expands Production Capability and Increases R&D with Newly Branded Bar Maker Division -- CFN Media

30/07/2018 - 15:00

SEATTLE, July 30, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

Sedor Pharmaceuticals NDA for CE-Fosphenytoin for Status Epilepticus Receives PDUFA Date

30/07/2018 - 14:58

Potential significant advance for life threatening condition PAOLI, Pa., July 30, 2018 (GLOBE NEWSWIRE) -- Sedor Pharmaceuticals, LLC (Sedor) announced that the US FDA accepted its 505(b)2 NDA (210864) for Sedor’s lead [...]

Teligent, Inc. Announces FDA Approval of Hydrocortisone Lotion USP, 2.5%

30/07/2018 - 14:30

BUENA, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

AIT Therapeutics Announces Start of Manufacturing of Ventilator Compatible NO Generator and Delivery System

30/07/2018 - 14:30

FDA 510(k) submission expected in the first quarter of calendar 2019 Sparton's Watertown facility to provide manufacturing services GARDEN CITY, N.Y. and REHOVOT, Israel, July 30, 2018 (GLOBE NEWSWIRE) -- AIT [...]

Iovance Biotherapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018

30/07/2018 - 14:01

SAN CARLOS, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]

Immunomedics Announces Multiple Clinical and Preclinical Collaborations With Prominent Cancer Research Institutions

30/07/2018 - 14:00

Clinical Collaboration with Yale University to Evaluate Sacituzumab Govitecan in Two Phase 2 Studies in Endometrial and Cervical Cancers Research Collaborations with Yale University, Memorial Sloan Kettering Cancer [...]

Pernix Therapeutics Announces Successful Closing of Transaction Regarding Worldwide Rights to Contrave® for Weight Loss

30/07/2018 - 14:00

MORRISTOWN, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced the closing of a transaction in which Nalpropion Pharmaceuticals [...]